Vacunación durante el embarazo

1. Kachikis A, Englund JA (2016) Maternal immunization: optimizing protection for the mother and infant. J Inf Secur 72(Suppl):S83–S90

2. Maertens K, Cabore RN, Huygen K, Hens N, Van Damme P, Leuridan E (2016) Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study. Vaccine 34:142–150

3. Maertens K, De Schutter S, Braeckman T, Baerts L, Van Damme P, De Meester I, Leuridan E (2014) Breastfeeding after maternal immunisation during pregnancy: providing immunological protection to the newborn: a review. Vaccine 32:1786–1792

4. Calvert A, Jones CE (2017) Placental transfer of antibody and its relationship to vaccination in pregnancy. Curr Opin Infect Dis 30: 268–273

5. Faucette AN, Unger BL, Gonik B, Chen K (2015) Maternal vaccination: moving the science forward. Hum Reprod Update 21:119–135

6. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M (2012) IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012:985646

7. Abu-Raya B, Smolen KK, Willems F, Kollmann TR, Marchant A (2016) Transfer of maternal antimicrobial immunity to HIV exposed uninfected newborns. Front Immunol 7:338

8. De Schutter S, Maertens K, Baerts L, DeMeester I, Van Damme P, Leuridan E (2015) Quantification of vaccine-induced antipertussis toxin secretory IgA antibodies in breast milk: comparison of different vaccination strategies in women. Pediatr Infect Dis J 34:e149–e152

9. Abu Raya B, Srugo I, Kessel A, Peterman M, Bader D, Peri R, Ashtamker N, Gonen R, Bamberger E (2014) The induction of breast milk pertussis specific antibodies following gestational

tetanus-diphtheria-acellular pertussis vaccination. Vaccine 32: 5632–5637

10. Demers-Mathieu V, Underwood MA, Beverly RL, Nielsen SD, Dallas DC (2018) Comparison of human milk immunoglobulin survival during gastric digestion between preterm and term infants. Nutrients 10

11. Eberhardt CS, Blanchard-Rohner G, Lemaitre B, Combescure C, Othenin-Girard V, Chilin A, Petre J, Martinez de Tejada B, Siegrist CA (2017) Pertussis antibody transfer to preterm neonates after second- versus third-trimester maternal immunization. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64:1129–1132

12. Malek A, Sager R, Schneider H (1994) Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy. Am J Reprod Immunol 32:8–14

13. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P (2010) Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. Bmj 340:c1626

14. Hoang HT, Leuridan E, Maertens K, Nguyen TD, Hens N, Vu NH, Cabore RN, Duong HT, Huygen K, Van Damme P, Dang AD (2016) Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial. Vaccine 34:151–159

15. Voysey M, Pollard AJ, Sadarangani M, Fanshawe TR (2017) Prevalence and decay of maternal pneumococcal and meningococcal antibodies: a meta-analysis of type-specific decay rates. Vaccine 35:5850–5857

16. Vilajeliu A, Ferrer L, Munros J, Gonce A, Lopez M, Costa J, Bayas JM (2016) Pertussis vaccination during pregnancy: antibody persistence in infants. Vaccine 34:3719–3722

17. Marchant A, Sadarangani M, Garand M, Dauby N, Verhasselt V, Pereira L, Bjornson G, Jones CE, Halperin SA, Edwards KM, Heath P, Openshaw PJ, Scheifele DW, Kollmann TR (2017) Maternal immunisation: collaborating with mother nature. Lancet Infect Dis 17:e197–e208

18. Orije MRP, Maertens K, Corbiere V, Wanlapakorn N, Van Damme P, Leuridan E, Mascart F (2020) The effect of maternal antibodies on the cellular immune response after infant vaccination: a review. Vaccine 38:20–28

19. Niewiesk S (2014) Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 5:446

20. WHO (2019) Protecting all against tetanus. Guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations.

21. Thwaites CL, Beeching NJ, Newton CR (2015) Maternal and neonatal tetanus. Lancet 385:362–370

22. Stanfield JP, Galazka A (1984) Neonatal tetanus in the world today. Bull World Health Organ 62:647–669

23. United Nations Children’s Fund / World Health Organization / United Nations Population Fund (2002) Maternal and neonatal tetanus elimination by 2005: strategies for achieving and maintaining elimination.

24. Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, Clark TA (2018) Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 67:1–44

25. Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S (2010) Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol 39(Suppl 1):i102–i109

26. WHO (2018) Global Health Observatory (GHO) data. Diphtheria-tetanus-pertussis (DTP3) immunization coverage

27. Sealey KL, Belcher T, Preston A (2016) Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence. Infect Genet Evol 40:136–143

28. Masseria C, Martin CK, Krishnarajah G, Becker LK, Buikema A, Tan TQ (2017) Incidence and burden of pertussis among infants less than 1 year of age. Pediatr Infect Dis J 36:e54–e61

29. Public Health England (2016) Vaccination against pertussis (Whooping cough) for pregnant women - 2016: information for healthcare professionals

30. Centers for Disease Control and Prevention (2013) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women–Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 62:131–135

31. McHugh L, Marshall HS, Perrett KP, Nolan T, Wood N, Lambert SB, Richmond P, Ware RS, Binks P, Binks MJ, Andrews RM (2019) The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012-2015: the Flu Mum Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 68:402–408

32. McMillan M, Clarke M, Parrella A, Fell DB, Amirthalingam G, Marshall HS (2017) Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy: a systematic review. Obstet Gynecol 129:560–573

33. Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ (2014) Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. Jama 311:1760–1769

34. Huygen K, Cabore RN, Maertens K, Van Damme P, Leuridan E (2015) Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and non pregnant women. Vaccine 33:4117–4123

35. Abu Raya B, Srugo I, Kessel A, Peterman M, Vaknin A, Bamberger E (2015) The decline of pertussis-specific antibodies after tetanus, diphtheria, and acellular pertussis immunization in late pregnancy. J Infect Dis 212:1869–1873

36. Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Fry NK, RamsayM(2015)A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 60:333–337

37. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M (2014) Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 384:1521–1528

38. Amirthalingam G, Campbell H, Ribeiro S, Fry NK, Ramsay M, Miller E, Andrews N (2016) Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 63:S236–s243

39. Abu-Raya B, Edwards KM (2019) Optimizing the timing of vaccine administration during pregnancy. Jama 321:935–936

40. Naidu MA, Muljadi R, Davies-Tuck ML, Wallace EM, Giles ML (2016) The optimal gestation for pertussis vaccination during pregnancy: a prospective cohort study. American journal of obstetrics

and gynecology 215:237.e231-236

41. Eberhardt CS, Blanchard-Rohner G, Lemaitre B, Boukrid M, Combescure C, Othenin-Girard V, Chilin A, Petre J, de Tejada BM, Siegrist CA (2016)Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 62:829–836

42. Englund JA, Anderson EL, Reed GF, Decker MD, Edwards KM, Pichichero ME, Steinhoff MC, Rennels MB, Deforest A, Meade BD (1995) The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 96:580–584

43. Maertens K, Cabore RN, Huygen K, Vermeiren S, Hens N, Van Damme P, Leuridan E (2016) Pertussis vaccination during pregnancy in Belgium: follow-up of infants until 1 month after the fourth